Drug: Oxymorphone ER: chronic pain clinical trials
Registry records that list "Drug: Oxymorphone ER" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone NCT00945919 | Unknown status | Not applicable | United States | Icahn School of Medicine at Mount Sinai | 2009-07 |
| Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning NCT00930943 | Completed | Phase 4 | United States | MedVadis Research Corporation | 2009-05 |
| Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects NCT00765856 | Terminated | Phase 3 | United States | Endo USA Inc., a Keenova Therapeutics Company | 2008-11-17 |
| Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy NCT00904280 | Completed | Phase 3 | United States | Endo USA Inc., a Keenova Therapeutics Company | 2001-03 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.